Klin Farmakol Farm. 2013;27(1):18-28

Appropriate choice of drugs and drug dosing in geriatric patients (Section I.), drug-disease interactions in the old age (Section II.)

Vhodnost volby léčiv a dávkovacích schémat u geriatrických pacientů (Oddíl I.);
interakce lék&ndash,nemoc ve stáří (Oddíl II.)

Explicit criteria for potentially inappropriate medication use in old age belong to the fundamental instruments of rational prescribing in

geriatric patients and have been widely used in computerized prescribing softwares, educational materials and epidemiological studies.

In the past decades, many explicit criteria were published, particularly with a special focus to rational selection of drugs in geriatric patients,

geriatric dosing, main drug-disease interactions and medications having substantial benefit in geriatric patients and often being

underused. The explicit criteria published are always specific for the pharmaceutical market of the home country and nonspecific for

the drug policy of the Czech Republic (CZ). They include medications not approved in the Czech Republic and some inappropriate medications,

widely used in our country, are not stated. The aim of our research was to develop explicit criteria for medications potentially

inappropriate in old age applicable in the Czech Republic (in the national drug policy, clinical practice and epidemiological studies). The

criteria were developed using a standard 3-round Delphi method, frequently used to create explicit criteria, during a 3-year research

of a team of the Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Prague, Czech Republic (2008–2011) and in a close

cooperation with a multidisciplinary expert group of 15 experts from the fields of geriatrics, internal medicine, general practice medicine,

clinical pharmacy and clinical pharmacology. The criteria for evaluation by the expert group were obtained by literature search of all

explicit criteria of potentially inappropriate prescribing/medications published between 1997–2011 in peer-reviewed journals or jour19

www.klinickafarmakologie.cz | 2013; 27(1) | Klinická farmakologie a farmacie

Hlavní téma

nals with an impact factor. According to a consensus of the expert group, 121 criteria were finally included in the Czech explicit criteria:

74 criteria for medications potentially inappropriate in old age (Section I) and 46 criteria for drug-disease interactions (Section II). The

article summarizes (in a short version) Section I and Section II of the new expert panel criteria for the Czech Republic. It also includes

comments on Section I from the updated Beers criteria published by the American Geriatric Society (AGS) in 2012 and discusses the basic

results of epidemiological studies implementing the 2003 Beers and STOPP/START criteria in the evaluation of rational drug prescribing

in geriatric patients in the Czech Republic.

Keywords: medications potentially inappropriate in the elderly, drug-disease interactions, 2012 Expert Consensus for the Czech Republic

Published: May 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
volby léčiv a dávkovacích schémat u geriatrických pacientů (Oddíl ) VI. Appropriate choice of drugs and drug dosing in geriatric patients (Section I.), drug-disease interactions in the old age (Section II.). Klin Farmakol Farm. 2013;27(1):18-28.
Download citation

References

  1. Page RL, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 2010; 5: 75-87. Go to original source... Go to PubMed...
  2. Fialová D. Specifické rysy geriatrické farmakoterapie. I - Změna terapeutické hodnoty léku ve stáří. Praha 2007, Karolinum, 90 s.
  3. Beard K. Adverse reactions as a cause of hospital admission in the aged. Drugs Aging 1992; 2(4): 356-367. Go to original source... Go to PubMed...
  4. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42(7): 1017-1025. Go to original source... Go to PubMed...
  5. Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging 2012; 29(6): 453-462. Go to original source... Go to PubMed...
  6. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24(2): 46-54. Go to original source... Go to PubMed...
  7. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004; 329(7456): 15-19. Go to original source... Go to PubMed...
  8. Somers A, Petrovic M, Robays H, Bogaert M. Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol. 2003; 58(10): 707-714. Go to original source... Go to PubMed...
  9. Spinewine A, Fialová D, Byrne S. The role of pharmacists in Optimizing Pharmacotherapy in Older People. Drugs Aging 2012; 29(6): 495-510. Go to original source... Go to PubMed...
  10. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing. 1992; 21(4): 294-300. Go to original source... Go to PubMed...
  11. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168(17): 1890-1896.
  12. Beswick A, Burke M, Shlomo YB, Dieppe P. PREDICT. Increasing the participation of elderly in clinical trials. Work package 1. Literature review. Medical Research Council (MERCS), Nov 2008: 143.
  13. Godlovitch G. Age discrimination in trials and treatment: old dogs and new tricks. Monash Bioeth Rev 2003; 22: 66-77. Go to original source... Go to PubMed...
  14. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-72. Go to original source... Go to PubMed...
  15. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007; 370(9582): 173-184. Go to original source... Go to PubMed...
  16. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J. Clin. Epidemiol. 1992; 45(10), 1045-1051. Go to original source... Go to PubMed...
  17. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck J. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991; 151: 1825-1832. Go to original source...
  18. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: An Update. Arch Intern Med. 1997; 157: 1531-1536. Go to original source...
  19. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Arch Intern Med. 2003; 163: 2716-2724. Go to original source... Go to PubMed...
  20. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2012; 60(4): 616-631. Go to original source... Go to PubMed...
  21. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screeening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Int J Clin Pharm and Therapeutics. 2007; 45: 1-12.
  22. Daleky N, Brown B, Cochran S. The Delphi Metod, III: Use of Self Ratings to Improve Group Estimates. Santa Monica, California: Rand Corp; November 1969. Publication RM-6115-PR.
  23. Chang CB, Chan DC. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging 2010, 27(12): 947-957. Go to original source... Go to PubMed...
  24. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA 2001; 286: 2823-2829. Go to original source... Go to PubMed...
  25. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997; 156: 385-391. Go to PubMed...
  26. Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Grégoire JP. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004; 4: 9. Go to original source... Go to PubMed...
  27. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725-731. Go to original source... Go to PubMed...
  28. Topinková E, Fialová D, Matějovská Kubešová H. Potenciálně nevhodná (riziková) léčiva u seniorů: Expertní konsensus pro Českou republiku 2012. Praktický lékař 2012; 92(1): 11-22.
  29. Fialová D, Topinková E, Gambassi G, et al. AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293(11): 1348-1358. Go to original source... Go to PubMed...
  30. Final conference of the SHELTER project: Long Term Care of Europe's Older Citizens: Policy and Fact. Providing data to support the relationship between care practice and quality of care in long term care facilities in Europe. International Press Centre, Brussels 2011 (Dec 5th).
  31. Fialová D, Topinková E. Koncept léčiv nevhodných ve stáří - farmakologické a farmakoepidemiologické aspekty. Remedia 2005; 15(4-5): 410-417.
  32. Topinková E, Mádlová P, Fialová D, Klán J. [New evidence-based criteria for evaluating the appropriateness of drug regimen in seniors. Criteria STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment)]. Vnitr Lek. 2008; 54(12): 1161-1169. Go to PubMed...
  33. Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011; 67(11): 1175-1188. Go to original source... Go to PubMed...
  34. Vinšová J, Fialová D, Topinková E, Vlček J, Wawruch M, Vitásek Z. Prevalence a vývojové trendy v preskripci léčiv potenciálně nevhodných ve stáří v ČR. Prakt lék 2006; 86(12): 722-728.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.